Hamm M - Search Results

1

Elimination kinetics of prostate-specific antigen serum and urine.

Semjonow A, Hamm M, Rathert P. Semjonow A, et al. Among authors: hamm m. Int J Biol Markers. 1994;9(1):15-20. doi: 10.1177/172460089400900103. Int J Biol Markers. 1994. PMID: 7519649

2

Combining free and total prostate specific antigen assays from different manufacturers: the pitfalls.

Oberpenning F, Weining C, Brandt B, De Angelis G, Heinecke A, Hamm M, Stieber P, Hertle L, Schmid HP, Semjonow A. Oberpenning F, et al. Among authors: hamm m. Eur Urol. 2002 Dec;42(6):577-82; discussion 582. doi: 10.1016/s0302-2838(02)00449-9. Eur Urol. 2002. PMID: 12477653

3

A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.

Oberpenning F, Weining C, Brandt B, De Angelis G, Heinecke A, Hamm M, Stieber P, Hertle L, Schmid HP, Semjonow A. Oberpenning F, et al. Among authors: hamm m. Clin Chem Lab Med. 2003 Jan;41(1):90-4. doi: 10.1515/CCLM.2003.016. Clin Chem Lab Med. 2003. PMID: 12636056 Free article.

4

Half-life of prostate-specific antigen after radical prostatectomy: the decisive predictor of curative treatment?

Semjonow A, Hamm M, Rathert P. Semjonow A, et al. Among authors: hamm m. Eur Urol. 1992;21(3):200-5. doi: 10.1159/000474838. Eur Urol. 1992. PMID: 1379927

5

Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen.

Semjonow A, Hamm M, Rathert P. Semjonow A, et al. Among authors: hamm m. World J Urol. 1993;11(4):218-20. doi: 10.1007/BF00185073. World J Urol. 1993. PMID: 7508787

6

Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.

Semjonow A, Hamm M, Rathert P, Hertle L. Semjonow A, et al. Among authors: hamm m. Br J Urol. 1994 May;73(5):538-43. doi: 10.1111/j.1464-410x.1994.tb07640.x. Br J Urol. 1994. PMID: 7516808

7

Radical prostatectomy: survival outcome and correlation to prostate-specific antigen levels.

Oberpenning F, Hamm M, Schmid HP, Hertle L, Semjonow A. Oberpenning F, et al. Among authors: hamm m. Anticancer Res. 2000 Nov-Dec;20(6D):4969-72. Anticancer Res. 2000. PMID: 11326649

8

Re: Nontraumatic elevation of prostate specific antigen following cardiac surgery and extracorporeal cardiopulmonary bypass.

Semjonow A, Roth S, Hamm M, Rathert P. Semjonow A, et al. Among authors: hamm m. J Urol. 1996 Jan;155(1):295-6. doi: 10.1016/s0022-5347(01)66640-0. J Urol. 1996. PMID: 7490870 No abstract available.

9

[The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].

Semjonow A, Hamm M, Rathert P. Semjonow A, et al. Among authors: hamm m. Urologe A. 1993 May;32(3):250-3. Urologe A. 1993. PMID: 7685557 German.

10

Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?

Semjonow A, Oberpenning F, Weining C, Schön M, Brandt B, De Angelis G, Heinecke A, Hamm M, Stieber P, Hertle L, Schmid HP. Semjonow A, et al. Among authors: hamm m. Clin Chem. 2001 Aug;47(8):1472-5. Clin Chem. 2001. PMID: 11468242 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters